Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/149300 stock hub

XKON/149300 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/149300is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/149300

In the news

Latest news · XKON/149300

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-54.8

P25 n/aP50 n/aP75 n/a

ROIC-11

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/149300 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

KRW

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 1.3B
Price	KRW 28
Price currency	KRW
Sic	2836
Symbol	xkon/149300
Website	https://www.apures.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-293.26%
FCF yield	-460.91%
P/B ratio	0.2x
P/S ratio	2.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	43.32%
Gross Profit	KRW 224.1M
Gross Profit Growth	143.23%
Gross Profit Growth Q	-95.93%
Gross Profit Growth3 Y	-3.34%
Net Income	KRW -3.7B
Pretax Margin	-723.51%
ROA	-10.28
ROCE	-17.72
ROE	-54.78
ROIC	-11.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-90.83%
Cagr3y	-70.39%
Cagr5y	-59.15%
Revenue Growth	-0.13x
Revenue Growth Q	-35.42x
Revenue Growth3 Y	2.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.03
Assets	KRW 21.9B
Cash	KRW 2.9B
Current Assets	KRW 3.7B
Current Liabilities	KRW 3.1B
Debt	KRW 13.6B
Debt Equity	KRW 2.12
Debt FCF	KRW -2.31
Equity	KRW 6.4B
Interest Coverage	-4.01
Liabilities	KRW 15.5B
Long Term Assets	KRW 18.2B
Long Term Liabilities	KRW 12.4B
Net Cash	KRW -10.7B
Net Cash By Market Cap	KRW -836
Net Debt Equity	KRW 1.66
Tangible Book Value	KRW 6.4B
Tangible Book Value Per Share	KRW 236
WACC	4.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.19
Inventory Turnover	1.68
Net Working Capital	KRW -728.1M
Quick ratio	0.97
Working Capital	KRW 586.2M
Working Capital Turnover	KRW -0.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.93%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-90.82%
200-day SMA	74.1
3Y total return	-97.41%
50-day SMA	40.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.86%
All Time High	4,000
All Time High Change	-99.3%
All Time High Date	2020-12-10
All Time Low	17
All Time Low Change	64.71%
All Time Low Date	2025-12-30
ATR	5.42
Beta	-0.44
Beta1y	1.25
Beta2y	0.17
Ch YTD	21.74
High	31
High52	367
High52 Date	2025-03-31
High52ch	-92.37%
Low	28
Low52	17
Low52 Date	2025-12-30
Low52ch	64.71%
Ma50ch	-30.28%
Price vs 200-day SMA	-62.21%
RSI	31.81
RSI Monthly	33.32
RSI Weekly	37.14
Sharpe ratio	-1.2x
Sortino ratio	-1.6
Total Return	-7.93%
Tr YTD	21.74
Tr1m	-20%
Tr1w	-22.22%
Tr3m	-12.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -3.3B
Operating margin	-643.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,640,321%
Net Borrowing	-5,629,920,540
Shares Insiders	3.85%
Shares Institutions	13.03%
Shares Out	45,486,252
Shares Qo Q	-1.93%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -5.9B
Average Volume	57,691.4x
Bv Per Share	238
CAPEX	KRW -3.1B
Ch1m	-20
Ch1w	-22.22
Ch1y	-90.82
Ch3m	-12.5
Ch3y	-97.41
Ch5y	-98.86
Ch6m	-80.42
Change	0%
Change From Open	-6.67
Close	28
Days Gap	7.14
Depreciation Amortization	1,458,920,840
Dollar Volume	1,508,724
EBIT	KRW -3.3B
EBITDA	KRW -1.9B
EPS	KRW -139
F Score	3
FCF	KRW -5.9B
FCF Per Share	KRW -129
Financing CF	7,146,510,810
Fiscal Year End	December
Founded	2,001
Income Tax	KRW -8M
Investing CF	-2,971,932,540
Is Primary Listing	1
Last Report Date	2019-06-30
Ma150	79.5
Ma150ch	-64.78%
Ma20	35.85
Ma20ch	-21.9%
Net CF	1,365,147,560
Open	30
Position In Range	0
Ppne	17,852,726,030
Price Date	2026-03-23
Ptbv Ratio	0.2
Relative Volume	0.93x
Revenue	517,334,160x
Tax By Revenue	-1.54x
Tr6m	-80.42%
Volume	53,883
Z Score	-1.96

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/149300 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/149300 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/149300?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.0%

Share of float held by funds and institutions

Insider ownership

+3.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/149300 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.8

Neutral momentum band

Price vs 200-day MA

-62.2%

50/200-day relationship not available

Beta (5Y)

-0.44

Less volatile than the market

Sharpe ratio

-1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/149300

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/149300 stock rating?

xkon/149300 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/149300 analysis?

The full report lives at /stocks/xkon/149300/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/149300?

The latest report frames xkon/149300 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/149300 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.